| Financier | Commitments |
|---|---|
| IDA Credit | 20.00 |
Papua New Guinea COVID-19 Emergency Response Project
Abstract*
The Project aims to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health in PNG by improving emergency preparedness and response, strengthening health systems and managing implementation and monitoring & evaluation. The Project will have a national footprint although some activities are restricted to 10 priority provinces. Show More
Development Objective
To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Papua New Guinea (PNG).
Key Details
Project Details
P173834
Active
Nang Kham
Independent State of Papua New Guinea
Papua New Guinea
April 7, 2020
(as of board presentation)
April 10, 2020
April 17, 2020
US$ 20.00 million
National Department of Health
2020
US$ 20.00 million
N/A
May 10, 2024
April 15, 2025
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 20.00 |
| IBRD + IDA Commitment | 20.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 20.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Apr 15, 2023 | IDA-66140 | Int Charges | 53,134.17 |
| Apr 15, 2023 | IDA-66140 | Int Charges | 4,860.80 |
| Apr 15, 2023 | IDA-66140 | Int Charges | 4,860.80 |
| Feb 22, 2023 | IDA-67850 | Loan Disb | 11,114.46 |
| Apr 19, 2023 | IDA-67850 | Loan Cancel | 10,576,670.00 |
| Apr 19, 2023 | IDA-67970 | Loan Cancel | 9,423,330.00 |
| Feb 28, 2023 | IDA-66140 | Loan Disb | 13,968.03 |
| May 16, 2023 | IDA-66140 | Loan Disb | 40,919.42 |
| Sep 12, 2023 | IDA-66140 | Loan Disb | 44,642.84 |
| Sep 12, 2023 | IDA-66140 | Loan Disb | 41,075.06 |
| Sep 26, 2023 | IDA-66140 | Loan Disb | 42,421.11 |
| Sep 27, 2022 | IDA-66140 | Loan Disb | 14,376.45 |
| Sep 9, 2022 | IDA-66140 | Loan Disb | 13,218.95 |
| Oct 15, 2022 | IDA-66140 | Int Charges | 50,526.28 |
| Oct 15, 2022 | IDA-66140 | Int Charges | 50,526.28 |
| Oct 15, 2022 | IDA-66140 | Int Charges | 90,711.68 |
| Dec 12, 2022 | IDA-67850 | Loan Disb | 8,646.37 |
| Dec 12, 2022 | IDA-67850 | Loan Disb | 8,476.05 |
| Jan 20, 2023 | IDA-66140 | Loan Disb | 12,756.61 |
| Oct 15, 2022 | IDA-66140 | Int Charges | 3,900.72 |
| Oct 15, 2022 | IDA-66140 | Int Charges | 3,900.72 |
| Apr 25, 2023 | IDA-66140 | Loan Disb | 27,368.40 |
| Mar 8, 2023 | IDA-66140 | Loan Disb | 31,789.99 |
| Apr 15, 2023 | IDA-66140 | Int Charges | 94,580.17 |
| Apr 4, 2023 | IDA-67850 | Loan Disb | 8,646.37 |
| Apr 5, 2023 | IDA-66140 | Loan Disb | 8,993.21 |
| Apr 4, 2023 | IDA-67850 | Loan Disb | 13,455.52 |
| Apr 4, 2023 | IDA-67850 | Loan Disb | 15,368.62 |
| Dec 12, 2022 | IDA-67850 | Loan Disb | 8,646.37 |
| Dec 12, 2022 | IDA-67850 | Loan Disb | 8,476.05 |
| May 12, 2022 | IDA-66140 | Loan Disb | 8,725.76 |
| Jun 5, 2024 | IDA-66140 | Loan Disb | 212,640.02 |
| Aug 21, 2024 | IDA-66140 | Loan Disb | 186,604.66 |
| Apr 16, 2024 | IDA-66140 | Loan Disb | 14,885.23 |
| Apr 16, 2024 | IDA-66140 | Loan Disb | 3,765.89 |
| Mar 7, 2024 | IDA-66140 | Loan Disb | 26,313.85 |
| Jul 16, 2024 | IDA-66140 | Loan Disb | 38,277.18 |
| Jul 3, 2024 | IDA-66140 | Loan Disb | 26,448.21 |
| Aug 7, 2024 | IDA-66140 | Loan Disb | 26,491.50 |
| Mar 5, 2024 | IDA-66140 | Loan Disb | 8,913.14 |
| Mar 11, 2024 | IDA-66140 | Loan Disb | 16,399.16 |
| May 13, 2024 | IDA-66140 | Loan Disb | 21,940.32 |
| Feb 6, 2024 | IDA-66140 | Loan Disb | 31,616.08 |
| Jun 6, 2024 | IDA-66140 | Loan Disb | 26,491.50 |
| Jan 8, 2024 | IDA-66140 | Loan Disb | 76,894.83 |
| Jan 8, 2024 | IDA-66140 | Loan Disb | 25,780.06 |
| Dec 11, 2023 | IDA-66140 | Loan Disb | 38,545.24 |
| Dec 11, 2023 | IDA-66140 | Loan Disb | 26,337.81 |
| Dec 11, 2023 | IDA-66140 | Loan Disb | 28,541.54 |
| Dec 11, 2023 | IDA-66140 | Loan Disb | 26,290.33 |
| Apr 5, 2024 | IDA-66140 | Loan Disb | 11,576.51 |
| Apr 15, 2024 | IDA-66140 | Int Charges | 373.61 |
| Apr 15, 2024 | IDA-66140 | Int Charges | 64,249.77 |
| Apr 15, 2024 | IDA-66140 | Int Charges | 64,249.77 |
| Apr 15, 2024 | IDA-66140 | Int Charges | 107,082.87 |
| Jul 25, 2024 | IDA-67850 | Loan Disb | 7,000,000.00 |
| Jul 26, 2024 | IDA-66140 | Loan Disb | 36,759.64 |
| Apr 12, 2024 | IDA-66140 | Loan Disb | 26,409.16 |
| Jun 22, 2021 | IDA-67850 | Loan Commitment | 20,000,000.00 |
| Jun 22, 2021 | IDA-67970 | Loan Commitment | 10,000,000.00 |
| Apr 10, 2020 | IDA-66140 | Loan Commitment | 20,000,000.00 |
| Apr 15, 2022 | IDA-66140 | Int Charges | 955.50 |
| Apr 15, 2022 | IDA-66140 | Int Charges | 955.50 |
| Apr 15, 2022 | IDA-66140 | Int Charges | 57,079.37 |
| Apr 15, 2022 | IDA-66140 | Int Charges | 57,079.37 |
| Apr 15, 2022 | IDA-66140 | Int Charges | 96,724.78 |
| Dec 22, 2021 | IDA-66140 | Loan Disb | 11,867.74 |
| Dec 7, 2021 | IDA-66140 | Loan Disb | 57,999.99 |
| Jan 28, 2022 | IDA-66140 | Loan Disb | 32,636.86 |
| Aug 19, 2022 | IDA-66140 | Loan Disb | 27,970.44 |
| Apr 15, 2021 | IDA-66140 | Int Charges | 60,406.22 |
| Apr 28, 2021 | IDA-66140 | Loan Disb | 5,682.96 |
| Oct 15, 2021 | IDA-66140 | Int Charges | 58,355.88 |
| Oct 15, 2021 | IDA-66140 | Int Charges | 58,355.88 |
| Oct 15, 2021 | IDA-66140 | Int Charges | 99,545.43 |
| Oct 15, 2021 | IDA-66140 | Int Charges | 1,371.37 |
| Oct 15, 2021 | IDA-66140 | Int Charges | 1,371.37 |
| Apr 15, 2021 | IDA-66140 | Int Charges | 161.27 |
| Apr 15, 2021 | IDA-66140 | Int Charges | 60,406.22 |
| Oct 27, 2020 | IDA-66140 | Loan Disb | 5,765.99 |
| May 26, 2020 | IDA-66140 | Loan Disb | 4,889,817.00 |
| May 28, 2020 | IDA-66140 | Loan Disb | 10,168,399.00 |
| May 20, 2020 | IDA-66140 | Loan Disb | 321,740.34 |
| Oct 13, 2020 | IDA-66140 | Loan Disb | 6,097.52 |
| Dec 14, 2020 | IDA-66140 | Loan Disb | 5,888.21 |
| Oct 15, 2020 | IDA-66140 | Int Charges | 45,648.85 |
| Oct 15, 2020 | IDA-66140 | Int Charges | 45,648.85 |
| Oct 15, 2020 | IDA-66140 | Int Charges | 75,922.05 |
| Apr 15, 2021 | IDA-66140 | Int Charges | 100,677.04 |
| Jul 26, 2024 | IDA-66140 | Loan Disb | 9,837.17 |
| Jul 26, 2024 | IDA-66140 | Loan Disb | 181,147.94 |
| May 31, 2024 | IDA-66140 | Loan Disb | 5,646.08 |
| May 31, 2024 | IDA-66140 | Loan Disb | 9,892.52 |
| Mar 20, 2024 | IDA-66140 | Loan Disb | 8,237.85 |
| Aug 29, 2024 | IDA-66140 | Loan Disb | 26,491.50 |
| Apr 15, 2024 | IDA-67850 | Int Charges | 19.39 |
| Apr 15, 2024 | IDA-67850 | Int Charges | 19.39 |
| May 8, 2024 | IDA-66140 | Loan Disb | 30,409.15 |
| Apr 15, 2024 | IDA-67850 | Int Charges | 414.27 |
| Apr 15, 2024 | IDA-67850 | Int Charges | 414.27 |
| Apr 15, 2024 | IDA-67850 | Int Charges | 722.79 |
| Apr 3, 2024 | IDA-66140 | Loan Disb | 19,327.72 |
| Jun 22, 2023 | IDA-66140 | Loan Disb | 43,821.82 |
| Sep 15, 2023 | IDA-66140 | Loan Disb | 1,602,820.00 |
| Oct 17, 2023 | IDA-67850 | Int Charges | 80.50 |
| Oct 17, 2023 | IDA-67850 | Int Charges | 418.40 |
| Oct 17, 2023 | IDA-67850 | Int Charges | 418.40 |
| Oct 17, 2023 | IDA-67850 | Int Charges | 697.35 |
| May 23, 2023 | IDA-67850 | Loan Disb | 17,384.63 |
| Oct 17, 2023 | IDA-66140 | Int Charges | 95,961.24 |
| Oct 17, 2023 | IDA-66140 | Int Charges | 2,011.37 |
| Oct 17, 2023 | IDA-66140 | Int Charges | 57,800.00 |
| Oct 17, 2023 | IDA-66140 | Int Charges | 57,800.00 |
| Nov 3, 2023 | IDA-66140 | Loan Disb | 33,461.21 |
| Dec 12, 2022 | IDA-67850 | Loan Disb | 8,646.37 |
| Apr 15, 2023 | IDA-67850 | Int Charges | 141.85 |
| Apr 15, 2023 | IDA-67850 | Int Charges | 141.85 |
| Apr 15, 2023 | IDA-67850 | Int Charges | 153.26 |
| Apr 11, 2023 | IDA-66140 | Loan Disb | 25,037.21 |
| Feb 27, 2023 | IDA-67850 | Loan Disb | 8,476.05 |
| Apr 15, 2023 | IDA-66140 | Int Charges | 53,134.17 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Project Management | Satisfactory | 2024-10-06 |
| Procurement | Moderately Satisfactory | 2024-10-06 |
| Financial Management | Moderately Unsatisfactory | 2024-10-06 |
| Progress towards achievement of PDO | Moderately Satisfactory | 2024-10-06 |
| Monitoring and Evaluation | Moderately Satisfactory | 2024-10-06 |
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-10-06 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Proportion of samples from suspected cases of COVID-19 / SARI that are confirmed within 48 hours Value 0.00 44.40 60.00 Date April 17, 2020 June 30, 2023 October 31, 2024 Comment Number of Provinces with personal protective equipment (PPE) and infection prevention & control (IPC) products and supplies, without stock-outs in preceding two weeks (Number) Value 0.00 22.00 22.00 Date April 17, 2020 December 31, 2023 October 31, 2024 Comment Proportion of laboratory-confirmed cases of COVID-19 responded to within 48 hours Value 0.00 15.00 30.00 Date May 5, 2020 December 31, 2023 October 31, 2024 Comment Proportion of samples from suspected cases of COVID-19/SARI of which testing is completed and reported within 48 hours (Male) Value 0.00 93.70 50.00 Date April 17, 2020 June 30, 2023 October 31, 2024 Comment Proportion of laboratory-confirmed cases of COVID-19 responded to within 48 hours (Male) Value 0.00 37.00 50.00 Date April 17, 2020 December 31, 2023 October 31, 2024 Comment Proportion of samples from suspected cases of COVID-19/SARI of which testing is completed and reported within 48 hours (Female) Value 0.00 6.30 50.00 Date May 7, 2020 June 30, 2023 October 31, 2024 Comment Proportion of laboratory-confirmed cases of COVID-19 responded to within 48 hours (Female) Value 0.00 63.00 50.00 Date April 17, 2020 December 31, 2023 October 31, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of designated laboratories with COVID-19/SARI diagnostic Polymerized Chain Reaction (PCR) and/or GeneXpert capacities established per NDOH guidelines Value 1.00 67.00 50.00 Date April 17, 2020 December 31, 2023 October 31, 2024 Comment Number of provincial hospitals with fully equipped isolation facilities Value 0.00 22.00 22.00 Date April 17, 2020 December 31, 2023 October 31, 2024 Comment Number of Provincial Hospitals that have a medical waste management plan in line with NDOH protocols Value 0.00 13.00 22.00 Date April 17, 2020 December 31, 2023 October 31, 2024 Comment Number of provincial hospitals with oxygen concentrators to manage COVID-19 patients Value 0.00 22.00 22.00 Date March 17, 2021 December 31, 2023 October 31, 2024 Comment Complaints to the Grievance Redress Mechanism (GRM) satisfactorily addressed within the specified timeframe of initial complaint being received Value 0.00 100.00 70.00 Date March 17, 2021 December 31, 2023 October 31, 2024 Comment Number of designated laboratories with COVID-19/SARI diagnostic PCR and/or GeneXpert capacity which has Biosafety Class II installed and certified Value 8.00 8.00 22.00 Date January 31, 2023 December 31, 2023 October 31, 2024 Comment